Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD: A Meta-Analysis of CKD Progression Trials.

Fletcher RA., Herrington WG., Agarwal R., Mayne KJ., Arnott C., Jardine MJ., Mahaffey KW., Perkovic V., Staplin N., Wheeler DC., Chertow GM., Heerspink HJL., Neuen BL.

This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2024_09_23_CJASNSeptember19992.mp3.

DOI

10.2215/CJN.0000000000000470

Type

Journal article

Journal

Clin J Am Soc Nephrol

Publication Date

01/09/2024

Volume

19

Pages

1180 - 1182

Keywords

CKD, cardiovascular, Humans, Sodium-Glucose Transporter 2 Inhibitors, Renal Insufficiency, Chronic, Disease Progression, Cardiovascular Diseases, Cause of Death

Permalink Original publication